Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Sepsis

Free Subscription Articles published in Infection Retrieve available abstracts of 93 articles: HTML format

Single Articles

October 2025
1. PRAGER M, Bergmann F, Pracher L, Copic D, et al
   Antimicrobial treatment for 7 versus 14 days in patients with bacteremia: a meta-analysis of randomized controlled trials.
   Infection. 2025;53:2159-2168.
   PubMed     Abstract available
   
   
   
2. ZIMMERMANN V, Fourre N, Senn L, Guery B, et al
   Predictors of mortality of enterococcal bacteraemia and the role of source control interventions; a retrospective cohort study.
   Infection. 2025;53:2149-2158.
   PubMed     Abstract available
   
   
   
3. WEBER F, Scharf C, Aulin LBS, Weinelt F, et al
   Model-informed identification of optimised dosing strategies for meropenem in critically ill patients receiving SLEDD: an observational study.
   Infection. 2025;53:1819-1831.
   PubMed     Abstract available
   
   
   
4. MANSSON TS, Askemyr A, Sunnerhagen T, Tham J, et al
   Piperacillin/tazobactam versus carbapenems for 30-day mortality in patients with ESBL-producing Enterobacterales bloodstream infections: a retrospective, multicenter, non-inferiority, cohort study.
   Infection. 2025;53:1769-1777.
   PubMed     Abstract available
   
   
   
5. MACPHAIL A, Chraiti MN, Nguyen A, Catho G, et al
   Epidemiology of hospital-acquired bloodstream infections in haemato-oncology patients in Geneva, Switzerland.
   Infection. 2025;53:1929-1939.
   PubMed     Abstract available
   
   
   
6. TEIXEIRA-ANTUNES A, Zimmermann V, Fourre N, Ianculescu N, et al
   Factors associated with persistent bacteraemia among patients with suspected infective endocarditis.
   Infection. 2025;53:2015-2024.
   PubMed     Abstract available
   
   
   
7. WOLF S, Weber S, Janetta A, Klein F, et al
   Epidemiology and outcomes of Candida spp. bloodstream infections in cancer patients: a comparative retrospective study from a German tertiary cancer center.
   Infection. 2025;53:1875-1885.
   PubMed     Abstract available
   
   
   
8. THIPMONTREE W, Lerssuttipon U, Chunharas P, Kajeekul R, et al
   Streptococcus suis endocarditis: prognostic factors and antimicrobial resistance.
   Infection. 2025;53:1779-1787.
   PubMed     Abstract available
   
   
   
9. MEINI S, Del Cesta R, Sbrana F, Rosada J, et al
   Clinical outcomes of patients hospitalized in internal medicine wards adequately treated for bloodstream infections caused by NDM-producing Klebsiella pneumoniae. Results from a real-life retrospective multi-center study in an endemic area.
   Infection. 2025;53:1737-1744.
   PubMed     Abstract available
   
   
   August 2025
10. BRACHT T, Weber M, Kappler K, Palmowski L, et al
    Machine learning identifies clinical sepsis phenotypes that translate to the plasma proteome.
    Infection. 2025 Aug 28. doi: 10.1007/s15010-025-02628.
    PubMed     Abstract available
    
    
    
11. SHAH S, Slaven B, Clarke LG, Ludwig J, et al
    Clinical and microbiologic outcomes of Stenotrophomonas maltophilia bloodstream infections.
    Infection. 2025;53:1483-1489.
    PubMed     Abstract available
    
    
    
12. FOURRE N, Zimmermann V, Senn L, Monney P, et al
    Comparison of the 2023 ISCVID and ESC Duke clinical criteria for the diagnosis of infective endocarditis among patients with positive blood cultures for new typical microorganisms.
    Infection. 2025;53:1393-1401.
    PubMed     Abstract available
    
    
    
13. RENGGLI L, Burri A, Ehrhard S, Gasser M, et al
    Incidence and resistance rates of Pseudomonas aeruginosa bloodstream infections in Switzerland: a nationwide surveillance study (2010-2022).
    Infection. 2025;53:1373-1381.
    PubMed     Abstract available
    
    
    
14. CAMP J, Heine V, Bayrhuber M, Anka N, et al
    Longterm efficacy of a patient focused intervention in patients with asplenia- a three year follow-up of the PrePPS trial.
    Infection. 2025;53:1449-1455.
    PubMed     Abstract available
    
    
    
15. KALBITZ S, Marx K, Kellner N, Glas A, et al
    Impact of adherence to quality indicators and effects of targeted treatment with cefazolin or flucloxacillin on in-hospital mortality in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bloodstream infections: a retrospective observa
    Infection. 2025;53:1457-1468.
    PubMed     Abstract available
    
    
    
16. FOSBOL EL, Stahl A, Roder A, Nordsten CB, et al
    Transurethral resection of the prostate (TUR-P) and associated risk of infective endocarditis.
    Infection. 2025;53:1351-1361.
    PubMed     Abstract available
    
    
    
17. KESSEL J, Bug G, Steffen B, Brunnberg U, et al
    Risk factors and outcome of Pseudomonas aeruginosa bloodstream infections (PABSI) in hematological patients: a single center retrospective cohort study.
    Infection. 2025;53:1383-1392.
    PubMed     Abstract available
    
    
    July 2025
18. JUNG C, Oetzmann N, Gillmann HJ, Stueber T, et al
    Identification and longitudinal assessment of sepsis phenotypes derived from routine clinical data in critically ill patients: a retrospective repeated measures latent profile analysis.
    Infection. 2025 Jul 23. doi: 10.1007/s15010-025-02607.
    PubMed     Abstract available
    
    
    
19. WEDEKIND L, Rose N, Freytag A, Kimmig A, et al
    Rehospitalizations for ambulatory care sensitive conditions in sepsis survivors- a nationwide cohort study using health claims data 2016-2019.
    Infection. 2025 Jul 18. doi: 10.1007/s15010-025-02606.
    PubMed     Abstract available
    
    
    
20. ALLEN VB, Bechman K, Russell MD, Adas MA, et al
    Rising rates of sepsis in England: an ecological study.
    Infection. 2025 Jul 15. doi: 10.1007/s15010-025-02601.
    PubMed     Abstract available
    
    
    
21. RUHNKE T, Storch J, Freytag A, Rose N, et al
    Transitional care after hospitalization for sepsis in Germany- results from the population-based AVENIR cohort study.
    Infection. 2025 Jul 8. doi: 10.1007/s15010-025-02589.
    PubMed     Abstract available
    
    
    June 2025
22. STEWART AG, Harris PNA, Edwards F, Kiani B, et al
    Klebsiella pneumoniae species complex bloodstream infection in adult patients: changing epidemiology and determinants of poor outcomes.
    Infection. 2025;53:1179-1187.
    PubMed     Abstract available
    
    
    
23. TISEO G, Galfo V, Carbonara S, Marino A, et al
    Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy.
    Infection. 2025;53:1041-1050.
    PubMed     Abstract available
    
    
    
24. ONORATO L, de Luca I, Salvati A, Monari C, et al
    Piperacillin/tazobactam vs. cefepime or carbapenems for the treatment of bloodstream infections due to bacteria producing chromosomal AmpC beta-lactamase: a systematic review and meta-analysis.
    Infection. 2025;53:1141-1153.
    PubMed     Abstract available
    
    
    
25. CHERNY SS, Brzezinski RY, Wasserman A, Adler A, et al
    Characterizing CRP dynamics during acute infections.
    Infection. 2025;53:1199-1203.
    PubMed     Abstract available
    
    
    May 2025
26. NEUMANN C, Leitner M, Bloos F, Lange D, et al
    Clinical value of circulating bioactive adrenomedullin for prediction of outcome and hydrocortisone response in sepsis patients-a post-hoc analysis of the HYPRESS trial.
    Infection. 2025 May 30. doi: 10.1007/s15010-025-02569.
    PubMed     Abstract available
    
    
    April 2025
27. ZHAO C, Liu P, Lin X, Wan C, et al
    The type VI secretion system as a potential predictor of subsequent bloodstream infection of carbapenem-resistant Klebsiella pneumoniae strains on intestinal colonization.
    Infection. 2025;53:667-678.
    PubMed     Abstract available
    
    
    
28. MISCHNIK A, Baltus H, Walker SV, Behnke M, et al
    Gram-negative bloodstream infections in six German university hospitals, 2016-2020: clinical and microbiological features.
    Infection. 2025;53:625-633.
    PubMed     Abstract available
    
    
    
29. WU JY, Liu MY, Liu TH, Huang PY, et al
    Effect of hydrocortisone-fludrocortisone combination on mortality in septic shock: a systematic review and meta-analysis.
    Infection. 2025;53:553-560.
    PubMed     Abstract available
    
    
    February 2025
30. G GURTLER L, Schramm W, Seitz R
    Viral sepsis - pathophysiology and disease manifestation.
    Infection. 2025 Feb 17. doi: 10.1007/s15010-025-02486.
    PubMed     Abstract available
    
    
    
31. STAROSTA AD, Ehler J, Loffler B, Tannapfel A, et al
    Echovirus serotype 11 induced sepsis in a young female patient with multiple sclerosis treated with anti-CD20 monoclonal antibody ocrelizumab.
    Infection. 2025 Feb 5. doi: 10.1007/s15010-025-02479.
    PubMed     Abstract available
    
    
    
32. JIN W, Yang D, Xu Z, Song J, et al
    Predicting the risk of invasive fungal infections in ICU sepsis population: the AMI risk assessment tool.
    Infection. 2025 Feb 3. doi: 10.1007/s15010-024-02465.
    PubMed     Abstract available
    
    
    
33. LEE CC, Ho CY, Hong MY, Hung YP, et al
    A simple scoring algorithm predicting paravertebral and/or iliopsoas abscess among adults with community-onset bloodstream infections: matters of PVL-producing Staphylococcus aureus.
    Infection. 2025;53:209-220.
    PubMed     Abstract available
    
    
    
34. LIN YC, Yang KY, Peng CK, Chan MC, et al
    Clinical outcomes of carbapenem-resistant gram-negative bacterial bloodstream infection in patients with end-stage renal disease in intensive care units: a multicenter retrospective observational study.
    Infection. 2025;53:197-207.
    PubMed     Abstract available
    
    
    
35. CASALE R, Boattini M, Comini S, Bastos P, et al
    Clinical and microbiological features of positive blood culture episodes caused by non-fermenting gram-negative bacilli other than Pseudomonas and Acinetobacter species (2020-2023).
    Infection. 2025;53:183-196.
    PubMed     Abstract available
    
    
    
36. PAPADIMITRIOU-OLIVGERIS M, Senn L, Jacot D, Guery B, et al
    Predictors of mortality of Pseudomonas aeruginosa bacteraemia and the role of infectious diseases consultation and source control; a retrospective cohort study.
    Infection. 2025;53:117-124.
    PubMed     Abstract available
    
    
    December 2024
37. MARGALIT I, Yahav D, Hoffman T, Tabah A, et al
    Presentation, management, and outcomes of older compared to younger adults with hospital-acquired bloodstream infections in the intensive care unit: a multicenter cohort study.
    Infection. 2024;52:2435-2443.
    PubMed     Abstract available
    
    
    
38. NAGAOKA K, Iwanaga N, Murai Y, Kawasuji H, et al
    Clinical phenotype of anaerobic bacteremia unaccompanied by detectable abscess lesion: a 10-year retrospective, multicenter, observational-cohort study.
    Infection. 2024;52:2415-2424.
    PubMed     Abstract available
    
    
    November 2024
39. VON DER FORST M, Back L, Tourelle KM, Gruneberg D, et al
    SeptAsTERS- SeptiCyte(R) RAPID as assessment tool for early recognition of sepsis - a prospective observational study.
    Infection. 2024 Nov 22. doi: 10.1007/s15010-024-02409.
    PubMed     Abstract available
    
    
    
40. GRASPEUNTNER S, Lupatsii M, van Zandbergen V, Dammann MT, et al
    Infants < 90 days of age with late-onset sepsis display disturbances of the microbiome-immunity interplay.
    Infection. 2024 Nov 14. doi: 10.1007/s15010-024-02396.
    PubMed     Abstract available
    
    
    October 2024
41. HORNUSS D, Gopel S, Walker SV, Tobys D, et al
    Epidemiological trends and susceptibility patterns of bloodstream infections caused by Enterococcus spp. in six German university hospitals: a prospectively evaluated multicentre cohort study from 2016 to 2020 of the R-Net study group.
    Infection. 2024;52:1995-2004.
    PubMed     Abstract available
    
    
    
42. BERGE A, Lundin J, Blackberg A, Sunnerhagen T, et al
    Non-betahemolytic streptococcal bacteremia, cardiac implantable electronic device, endocarditis, extraction, and outcome; a population-based retrospective cohort study.
    Infection. 2024;52:1911-1919.
    PubMed     Abstract available
    
    
    
43. MARANGOS M, Ioannou P, Senn L, Spiliopoulou A, et al
    Role of source control in critically ill candidemic patients: a multicenter retrospective study.
    Infection. 2024;52:1733-1743.
    PubMed     Abstract available
    
    
    
44. MONDAL U, Warren E, Bookstaver PB, Kohn J, et al
    Incidence and predictors of complications in Gram-negative bloodstream infection.
    Infection. 2024;52:1725-1731.
    PubMed     Abstract available
    
    
    September 2024
45. GENSEKE S, Berisha M, Teerstegen A, Meyer B, et al
    Lautropia mirabilis sepsis in immunodeficiency: first report and genomic features.
    Infection. 2024 Sep 6. doi: 10.1007/s15010-024-02388.
    PubMed     Abstract available
    
    
    August 2024
46. ALDEWERELD Z, Connolly B, Banks RK, Reeder R, et al
    Risk factors for prolonged infection and secondary infection in pediatric severe sepsis.
    Infection. 2024 Aug 8. doi: 10.1007/s15010-024-02355.
    PubMed     Abstract available
    
    
    
47. HUANG R, Lu TL, Liu RH
    Comparison of the accuracy of hematological parameters in the diagnosis of neonatal sepsis: a network meta-analysis.
    Infection. 2024 Aug 2. doi: 10.1007/s15010-024-02354.
    PubMed     Abstract available
    
    
    
48. FUKUSHIMA S, Hagiya H, Kuninaga N, Haruki Y, et al
    Adherence to and clinical utility of "quality indicators" for Staphylococcus aureus bacteremia: a retrospective, multicenter study.
    Infection. 2024;52:1527-1538.
    PubMed     Abstract available
    
    
    
49. TIETAVAINEN J, Seiskari T, Aittoniemi J, Huhtala H, et al
    Assessment of a novel BLOOMY score for predicting mortality in hospitalised adults with bloodstream infection.
    Infection. 2024;52:1511-1517.
    PubMed     Abstract available
    
    
    
50. FUSZL A, Schindler S, Heger F, Markowicz M, et al
    Recurrent, ICD-associated L. monocytogenes bacteraemia with multiple septic pulmonary embolisms over a 2-year period.
    Infection. 2024;52:1615-1620.
    PubMed     Abstract available
    
    
    June 2024
51. WITOWSKI A, Palmowski L, Rahmel T, Nowak H, et al
    Activation of the MAPK network provides a survival advantage during the course of COVID-19-induced sepsis: a real-world evidence analysis of a multicenter COVID-19 Sepsis Cohort.
    Infection. 2024 Jun 19. doi: 10.1007/s15010-024-02325.
    PubMed     Abstract available
    
    
    
52. ZAYET S, Gendrin V, Vuillemenot JB, Plantin J, et al
    Emergence of Campylobacter fetus bacteraemias in the last decade, France.
    Infection. 2024;52:1185-1187.
    PubMed    
    
    
    
53. ABUELAZM MT, Elzeftawy MA, Kamal MA, Badr H, et al
    Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium Falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials.
    Infection. 2024;52:707-722.
    PubMed     Abstract available
    
    
    
54. SCHMIDT-HELLERAU K, Breuninger M, Kessel J, Vehreschild MJGT, et al
    Flucloxacillin and cefazolin for treatment of Staphylococcus aureus bloodstream infection.
    Infection. 2024;52:1159-1163.
    PubMed     Abstract available
    
    
    
55. LI Y, Huang K, Yin J, Tan Z, et al
    Clinical evaluation of a multiplex droplet digital PCR for pathogen detection in critically ill COVID-19 patients with bloodstream infections.
    Infection. 2024;52:1027-1039.
    PubMed     Abstract available
    
    
    
56. BAEK YJ, Song JE, Kim EJ, Choi H, et al
    Trends, clinical characteristics, antimicrobial susceptibility patterns, and outcomes of Campylobacter bacteraemia: a multicentre retrospective study.
    Infection. 2024;52:857-864.
    PubMed     Abstract available
    
    
    May 2024
57. PRINZ JC, French LE
    Generalized pustular psoriasis of the 'von Zumbusch'-type: a sepsis mimic with low PCT values.
    Infection. 2024 May 2. doi: 10.1007/s15010-024-02276.
    PubMed    
    
    
    April 2024
58. LIYANARACHI KV, Mohus RM, Rogne T, Gustad LT, et al
    Chronic kidney disease and risk of bloodstream infections and sepsis: a 17-year follow-up of the population-based Trondelag Health Study in Norway.
    Infection. 2024 Apr 29. doi: 10.1007/s15010-024-02265.
    PubMed     Abstract available
    
    
    
59. LI L, Zhou L, Peng X, Zhang Z, et al
    Association of stress hyperglycemia ratio and mortality in patients with sepsis: results from 13,199 patients.
    Infection. 2024 Apr 28. doi: 10.1007/s15010-024-02264.
    PubMed     Abstract available
    
    
    
60. BOEKHOUD L, Schaap HMEA, Huizinga RL, Olgers TJ, et al
    Correction to: Predictive performance of NEWS and qSOFA in immunocompromised sepsis patients at the emergency department.
    Infection. 2024 Apr 26. doi: 10.1007/s15010-024-02282.
    PubMed    
    
    
    
61. LIANG M, Xu Y, Ren X, Huang D, et al
    The U-shaped association between serum osmolality and 28-day mortality in patients with sepsis: a retrospective cohort study.
    Infection. 2024 Apr 22. doi: 10.1007/s15010-024-02256.
    PubMed     Abstract available
    
    
    
62. VAN STAA TP, Pate A, Martin GP, Sharma A, et al
    Sepsis and case fatality rates and associations with deprivation, ethnicity, and clinical characteristics: population-based case-control study with linked primary care and hospital data in England.
    Infection. 2024 Apr 16. doi: 10.1007/s15010-024-02235.
    PubMed     Abstract available
    
    
    
63. BOEKHOUD L, Schaap HMEA, Huizinga RL, Olgers TJ, et al
    Predictive performance of NEWS and qSOFA in immunocompromised sepsis patients at the emergency department.
    Infection. 2024 Apr 12. doi: 10.1007/s15010-024-02247.
    PubMed     Abstract available
    
    
    
64. BANZ M, Stallmach A, Gassler N, Schulze PC, et al
    Fatal pulmonary hemorrhage, pneumothorax and skin necrosis caused by IRIS to an Aspergillus flavus infection in a young patient with metamizole associated agranulocytosis.
    Infection. 2024;52:685-690.
    PubMed     Abstract available
    
    
    March 2024
65. BERNINGHAUSEN C, Schwab F, Gropmann A, Leidel BA, et al
    Deficits in blood culture collection in the emergency department if sepsis is suspected: results of a retrospective cohort study.
    Infection. 2024 Mar 5. doi: 10.1007/s15010-024-02197.
    PubMed     Abstract available
    
    
    February 2024
66. PIEDMONT S, Goldhahn L, Swart E, Robra BP, et al
    Sepsis incidence, suspicion, prediction and mortality in emergency medical services: a cohort study related to the current international sepsis guideline.
    Infection. 2024 Feb 19. doi: 10.1007/s15010-024-02181.
    PubMed     Abstract available
    
    
    
67. ROSEAU-VINCENTI A, Forestier E, Lanoix JP, Ricard C, et al
    Empirical antibiotic therapy modalities for Enterobacteriaceae bloodstream infections in older patients and their impact on mortality: a multicentre retrospective study.
    Infection. 2024;52:155-163.
    PubMed     Abstract available
    
    
    
68. PAPADIMITRIOU-OLIVGERIS M, Guery B, Ianculescu N, Auberson D, et al
    Risk of embolic events before and after antibiotic treatment initiation among patients with left-side infective endocarditis.
    Infection. 2024;52:117-128.
    PubMed     Abstract available
    
    
    
69. CHRISTNER M, Abdennadher B, Wichmann D, Kluge S, et al
    The added value of (1,3)-beta-D-glucan for the diagnosis of Invasive Candidiasis in ICU patients: a prospective cohort study.
    Infection. 2024;52:73-81.
    PubMed     Abstract available
    
    
    January 2024
70. LENGQUIST M, Varadarajan A, Alestam S, Friberg H, et al
    Sepsis mimics among presumed sepsis patients at intensive care admission: a retrospective observational study.
    Infection. 2024 Jan 27. doi: 10.1007/s15010-023-02158.
    PubMed     Abstract available
    
    
    December 2023
71. JINDAL J, Launer D, France HS, Hey M, et al
    Preventable deaths involving sepsis in England and Wales, 2013-2022: a systematic case series of coroners' reports.
    Infection. 2023 Dec 11. doi: 10.1007/s15010-023-02140.
    PubMed     Abstract available
    
    
    
72. ZUERCHER P, Moser A, Garcia de Guadiana-Romualdo L, Llewelyn MJ, et al
    Discriminative performance of pancreatic stone protein in predicting ICU mortality and infection severity in adult patients with infection: a systematic review and individual patient level meta-analysis.
    Infection. 2023;51:1797-1807.
    PubMed     Abstract available
    
    
    
73. OSTERGAARD L, Voldstedlund M, Bruun NE, Bundgaard H, et al
    Recurrence of bacteremia and infective endocarditis according to bacterial species of index endocarditis episode.
    Infection. 2023;51:1739-1747.
    PubMed     Abstract available
    
    
    
74. CAMP J, Bayrhuber M, Anka N, Heine V, et al
    Efficacy of a novel patient-focused intervention aimed at increasing adherence to guideline-based preventive measures in asplenic patients: the PrePSS trial.
    Infection. 2023;51:1787-1795.
    PubMed     Abstract available
    
    
    
75. TOBUDIC S, Bahrs C, Schneider L, Paulussen E, et al
    Early treatment response to piperacillin/tazobactam in patients with bloodstream infections caused by non-ESBL ampicillin/sulbactam-resistant Escherichia coli: a binational cohort study.
    Infection. 2023;51:1749-1758.
    PubMed     Abstract available
    
    
    
76. LARCHER R, Laffont-Lozes P, Naciri T, Bourgeois PM, et al
    Continuous infusion of meropenem-vaborbactam for a KPC-3-producing Klebsiella pneumoniae bloodstream infection in a critically ill patient with augmented renal clearance.
    Infection. 2023;51:1835-1840.
    PubMed     Abstract available
    
    
    October 2023
77. GEISMANN F, Handschuh S, Malfertheiner M, Salzberger B, et al
    Short report: impact of selective reporting of antibiotic susceptibility testing on antibiotic use in patients with bloodstream infection with Enterococcus faecalis.
    Infection. 2023;51:1557-1562.
    PubMed     Abstract available
    
    
    
78. CHAMAT-HEDEMAND S, Dahl A, Ostergaard L, Arpi M, et al
    Streptococcal species as a prognostic factor for mortality in patients with streptococcal bloodstream infections.
    Infection. 2023;51:1513-1522.
    PubMed     Abstract available
    
    
    
79. LAUPLAND KB, Edwards F, Harris PNA, Paterson DL, et al
    Significant clinical differences but not outcomes between Klebsiella aerogenes and Enterobacter cloacae bloodstream infections: a comparative cohort study.
    Infection. 2023;51:1445-1451.
    PubMed     Abstract available
    
    
    September 2023
80. SKEI NV, Nilsen TIL, Mohus RM, Prescott HC, et al
    Correction: Trends in mortality after a sepsis hospitalization: a nationwide prospective registry study from 2008 to 2021.
    Infection. 2023 Sep 21. doi: 10.1007/s15010-023-02090.
    PubMed    
    
    
    
81. SCHWARZKOPF D, Rose N, Fleischmann-Struzek C, Boden B, et al
    Understanding the biases to sepsis surveillance and quality assurance caused by inaccurate coding in administrative health data.
    Infection. 2023 Sep 9. doi: 10.1007/s15010-023-02091.
    PubMed     Abstract available
    
    
    August 2023
82. SKEI NV, Nilsen TIL, Mohus RM, Prescott HC, et al
    Trends in mortality after a sepsis hospitalization: a nationwide prospective registry study from 2008 to 2021.
    Infection. 2023 Aug 12. doi: 10.1007/s15010-023-02082.
    PubMed     Abstract available
    
    
    
83. HENTRICH M, Boll B, Teschner D, Panse J, et al
    Impact of the insertion site of central venous catheters on central venous catheter-related bloodstream infections in patients with cancer: results from a large prospective registry.
    Infection. 2023;51:1153-1159.
    PubMed     Abstract available
    
    
    
84. SEGALA FV, Pafundi PC, Masciocchi C, Fiori B, et al
    Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study.
    Infection. 2023;51:1061-1069.
    PubMed     Abstract available
    
    
    
85. RENGGLI L, Gasser M, Buetti N, Kronenberg A, et al
    Increase in methicillin-susceptible Staphylococcus aureus bloodstream infections in Switzerland: a nationwide surveillance study (2008-2021).
    Infection. 2023;51:1025-1031.
    PubMed     Abstract available
    
    
    
86. ATAMNA A, Margalit I, Ayada G, Babich T, et al
    Outcomes of octogenarians and nonagenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study.
    Infection. 2023;51:1003-1012.
    PubMed     Abstract available
    
    
    June 2023
87. KIM SH, Jeon CH, Kim HT, Wi YM, et al
    Clinical characteristics and manifestations in patients with hypermucoviscous Klebsiella pneumoniae bacteremia from extra-hepatobiliary tract infection.
    Infection. 2023;51:689-696.
    PubMed     Abstract available
    
    
    
88. KOUIJZER IJE, Speijker LTD, Aarntzen EHJG, Rijnen WHC, et al
    Clinically unsuspected orthopedic implants during S. aureus bacteremia do not require additional diagnostic work-up.
    Infection. 2023;51:743-747.
    PubMed     Abstract available
    
    
    May 2023
89. TORVIK MA, Nymo SH, Nymo SH, Bjornsen LP, et al
    Correction: Patient characteristics in sepsis-related deaths: prevalence of advanced frailty, comorbidity, and age in a Norwegian hospital trust.
    Infection. 2023 May 12. doi: 10.1007/s15010-023-02046.
    PubMed    
    
    
    April 2023
90. REDA NM, Hassan RM, Salem ST, Yousef RHA, et al
    Prevalence and species distribution of Candida bloodstream infection in children and adults in two teaching university hospitals in Egypt: first report of Candida kefyr.
    Infection. 2023;51:389-395.
    PubMed     Abstract available
    
    
    
91. HACHISU Y, Tamura K, Murakami K, Fujita J, et al
    Invasive Haemophilus influenzae disease among adults in Japan during 2014-2018.
    Infection. 2023;51:355-364.
    PubMed     Abstract available
    
    
    March 2023
92. TORVIK MA, Nymo SH, Nymo SH, Bjornsen LP, et al
    Patient characteristics in sepsis-related deaths: prevalence of advanced frailty, comorbidity, and age in a Norwegian hospital trust.
    Infection. 2023 Mar 9. doi: 10.1007/s15010-023-02013.
    PubMed     Abstract available
    
    
    November 2022
93. LABORDE C, Deidda M, Bador J, Putot S, et al
    Apyrexia improves the prognostic value of quick SOFA in older patients with acute pneumonia or bacteremic urinary tract infection.
    Infection. 2022 Nov 29. doi: 10.1007/s15010-022-01953.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sepsis is free of charge.